<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">34192289</PMID><DateRevised><Year>2022</Year><Month>12</Month><Day>29</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">2666-6022</ISSN><JournalIssue CitedMedium="Internet"><Volume>5</Volume><PubDate><Year>2021</Year><Month>May</Month></PubDate></JournalIssue><Title>American heart journal plus : cardiology research and practice</Title><ISOAbbreviation>Am Heart J Plus</ISOAbbreviation></Journal><ArticleTitle>Post-Acute COVID-19 Syndrome and the cardiovascular system: What is known?</ArticleTitle><Pagination><StartPage>100025</StartPage><MedlinePgn>100025</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">100025</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.ahjo.2021.100025</ELocationID><Abstract><AbstractText>Post-Acute COVID-19 Syndrome (PACS) is defined by persistent symptoms &gt;3-4&#xa0;weeks after onset of COVID-19. The mechanism of these persistent symptoms is distinct from acute COVID-19 although not completely understood despite the high incidence of PACS. Cardiovascular symptoms such as chest pain and palpitations commonly occur in PACS, but the underlying cause of symptoms is infrequently known. While autopsy studies have shown that the severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) rarely causes direct myocardial injury, several syndromes such as myocarditis, pericarditis, and Postural Orthostatic Tachycardia Syndrome have been implicated in PACS. Additionally, patients hospitalized with acute COVID-19 who display biomarker evidence of myocardial injury may have underlying coronary artery disease revealed by the physiological stress of SARS-CoV-2 infection and may benefit from medical optimization. We review what is known about PACS and the cardiovascular system and propose a framework for evaluation and management of related symptoms.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Dixit</LastName><ForeName>Neal M</ForeName><Initials>NM</Initials><AffiliationInfo><Affiliation>Department of Medicine, David Geffen School of Medicine at UCLA, 757 Westwood Plaza, Los Angeles, CA 90095, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Churchill</LastName><ForeName>Austin</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>School of Medicine, David Geffen School of Medicine at UCLA, 10833 Le Conte Ave, Los Angeles, CA 90095, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nsair</LastName><ForeName>Ali</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Medicine, David Geffen School of Medicine at UCLA, 757 Westwood Plaza, Los Angeles, CA 90095, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Division of Cardiology, David Geffen School of Medicine at UCLA, 757 Westwood Plaza, Los Angeles, CA 90095, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hsu</LastName><ForeName>Jeffrey J</ForeName><Initials>JJ</Initials><AffiliationInfo><Affiliation>Department of Medicine, David Geffen School of Medicine at UCLA, 757 Westwood Plaza, Los Angeles, CA 90095, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Division of Cardiology, David Geffen School of Medicine at UCLA, 757 Westwood Plaza, Los Angeles, CA 90095, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Veterans Affairs Greater Los Angeles Healthcare System, 11301 Wilshire Blvd, Los Angeles, CA 90073, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>06</Month><Day>24</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Am Heart J Plus</MedlineTA><NlmUniqueID>101779333</NlmUniqueID><ISSNLinking>2666-6022</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">ACE2, angiotensin converting enzyme-2</Keyword><Keyword MajorTopicYN="N">AF/AFL, atrial fibrillation or flutter</Keyword><Keyword MajorTopicYN="N">CBT, cognitive behavioral therapy</Keyword><Keyword MajorTopicYN="N">CFS, Chronic Fatigue Syndrome</Keyword><Keyword MajorTopicYN="N">CMR, cardiac magnetic resonance imaging</Keyword><Keyword MajorTopicYN="N">CRP, C-reactive protein</Keyword><Keyword MajorTopicYN="N">CV, cardiovascular</Keyword><Keyword MajorTopicYN="N">Cardiology</Keyword><Keyword MajorTopicYN="N">Coronavirus Disease 2019</Keyword><Keyword MajorTopicYN="N">ECG, electrocardiography</Keyword><Keyword MajorTopicYN="N">ECV, extracellular volume</Keyword><Keyword MajorTopicYN="N">LGE, late gadolinium enhancement</Keyword><Keyword MajorTopicYN="N">Long COVID</Keyword><Keyword MajorTopicYN="N">Long-Haul COVID</Keyword><Keyword MajorTopicYN="N">MCAS, Mast Cell Activation Syndrome</Keyword><Keyword MajorTopicYN="N">MERS, Middle East Respiratory Syndrome</Keyword><Keyword MajorTopicYN="N">POTS, Post-Acute COVID-19 Syndrome</Keyword><Keyword MajorTopicYN="N">SARS-COV-1, Severe Acute Respiratory Syndrome Coronavirus-1</Keyword><Keyword MajorTopicYN="N">SARS-CoV-2</Keyword><Keyword MajorTopicYN="N">T1MI, type 1 myocardial infarction</Keyword><Keyword MajorTopicYN="N">T2MI, type 2 myocardial infarction</Keyword><Keyword MajorTopicYN="N">TTT, tilt table testing</Keyword></KeywordList><CoiStatement>The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>4</Month><Day>16</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2021</Year><Month>6</Month><Day>8</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2021</Year><Month>6</Month><Day>10</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>6</Month><Day>30</Day><Hour>17</Hour><Minute>33</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>7</Month><Day>1</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>7</Month><Day>1</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2021</Year><Month>6</Month><Day>24</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">34192289</ArticleId><ArticleId IdType="pmc">PMC8223036</ArticleId><ArticleId IdType="doi">10.1016/j.ahjo.2021.100025</ArticleId><ArticleId IdType="pii">S2666-6022(21)00023-9</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Baig A.M. Chronic COVID syndrome: need for an appropriate medical terminology for long-COVID and COVID long-haulers. J. Med. Virol. 2020 doi: 10.1002/jmv.26624. Oct 23.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.26624</ArticleId><ArticleId IdType="pubmed">33095459</ArticleId></ArticleIdList></Reference><Reference><Citation>Nabavi N. Long covid: how to define it and how to manage it. Bmj. 2020;370:m3489. doi: 10.1136/bmj.m3489. Sep 7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.m3489</ArticleId><ArticleId IdType="pubmed">32895219</ArticleId></ArticleIdList></Reference><Reference><Citation>Greenhalgh T., Knight M., A'Court C., Buxton M., Husain L. Management of post-acute covid-19 in primary care. Bmj. 2020;370:m3026. doi: 10.1136/bmj.m3026. Aug 11.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.m3026</ArticleId><ArticleId IdType="pubmed">32784198</ArticleId></ArticleIdList></Reference><Reference><Citation>Nalbandian A., Sehgal K., Gupta A., et al. Post-acute COVID-19 syndrome. Nat. Med. 2021 doi: 10.1038/s41591-021-01283-z. 2021/03/22.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-021-01283-z</ArticleId><ArticleId IdType="pmc">PMC8893149</ArticleId><ArticleId IdType="pubmed">33753937</ArticleId></ArticleIdList></Reference><Reference><Citation>Magadum A., Kishore R. Cardiovascular manifestations of COVID-19 infection. Cells. 2020;9(11) doi: 10.3390/cells9112508. Nov 19.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/cells9112508</ArticleId><ArticleId IdType="pmc">PMC7699571</ArticleId><ArticleId IdType="pubmed">33228225</ArticleId></ArticleIdList></Reference><Reference><Citation>Zheng Y.Y., Ma Y.T., Zhang J.Y., Xie X. COVID-19 and the cardiovascular system. Nat. Rev. Cardiol. May 2020;17(5):259&#x2013;260. doi: 10.1038/s41569-020-0360-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41569-020-0360-5</ArticleId><ArticleId IdType="pmc">PMC7095524</ArticleId><ArticleId IdType="pubmed">32139904</ArticleId></ArticleIdList></Reference><Reference><Citation>Majure D.T., Gruberg L., Saba S.G., Kvasnovsky C., Hirsch J.S., Jauhar R. Usefulness of elevated troponin to predict death in patients with COVID-19 and myocardial injury. Am. J. Cardiol. 2021;138:100&#x2013;106. doi: 10.1016/j.amjcard.2020.09.060. Jan 1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.amjcard.2020.09.060</ArticleId><ArticleId IdType="pmc">PMC7550867</ArticleId><ArticleId IdType="pubmed">33058800</ArticleId></ArticleIdList></Reference><Reference><Citation>Lippi G., Lavie C.J., Sanchis-Gomar F. Cardiac troponin I in patients with coronavirus disease 2019 (COVID-19): evidence from a meta-analysis. Prog. Cardiovasc. Dis. May-Jun 2020;63(3):390&#x2013;391. doi: 10.1016/j.pcad.2020.03.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.pcad.2020.03.001</ArticleId><ArticleId IdType="pmc">PMC7127395</ArticleId><ArticleId IdType="pubmed">32169400</ArticleId></ArticleIdList></Reference><Reference><Citation>Cordeanu E.M., Duthil N., Severac F., et al. Prognostic value of troponin elevation in COVID-19 hospitalized patients. J. Clin. Med. 2020;9(12) doi: 10.3390/jcm9124078. Dec 17.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm9124078</ArticleId><ArticleId IdType="pmc">PMC7766903</ArticleId><ArticleId IdType="pubmed">33348719</ArticleId></ArticleIdList></Reference><Reference><Citation>Linschoten M., Peters S., van Smeden M., et al. Cardiac complications in patients hospitalised with COVID-19. Eur. Heart J. Acute Cardiovasc. Care. Dec 2020;9(8):817&#x2013;823. doi: 10.1177/2048872620974605.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/2048872620974605</ArticleId><ArticleId IdType="pmc">PMC7734244</ArticleId><ArticleId IdType="pubmed">33222494</ArticleId></ArticleIdList></Reference><Reference><Citation>Kawakami R., Sakamoto A., Kawai K., et al. Pathological evidence for SARS-CoV-2 as a cause of myocarditis: JACC review topic of the week. J. Am. Coll. Cardiol. 2021;77(3):314&#x2013;325. doi: 10.1016/j.jacc.2020.11.031. Jan 26.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jacc.2020.11.031</ArticleId><ArticleId IdType="pmc">PMC7816957</ArticleId><ArticleId IdType="pubmed">33478655</ArticleId></ArticleIdList></Reference><Reference><Citation>Basso C., Leone O., Rizzo S., et al. Pathological features of COVID-19-associated myocardial injury: a multicentre cardiovascular pathology study. Eur. Heart J. 2020;41(39):3827&#x2013;3835. doi: 10.1093/eurheartj/ehaa664. Oct 14.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/eurheartj/ehaa664</ArticleId><ArticleId IdType="pmc">PMC7543528</ArticleId><ArticleId IdType="pubmed">32968776</ArticleId></ArticleIdList></Reference><Reference><Citation>Bilaloglu S., Aphinyanaphongs Y., Jones S., Iturrate E., Hochman J., Berger J.S. Thrombosis in hospitalized patients with COVID-19 in a New York City Health System. JAMA. 2020;324(8):799&#x2013;801. doi: 10.1001/jama.2020.13372.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2020.13372</ArticleId><ArticleId IdType="pmc">PMC7372509</ArticleId><ArticleId IdType="pubmed">32702090</ArticleId></ArticleIdList></Reference><Reference><Citation>Loo J., Spittle D.A., Newnham M. COVID-19, immunothrombosis and venous thromboembolism: biological mechanisms. Thorax. 2021;76(4):412. doi: 10.1136/thoraxjnl-2020-216243.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/thoraxjnl-2020-216243</ArticleId><ArticleId IdType="pubmed">33408195</ArticleId></ArticleIdList></Reference><Reference><Citation>Argulian E., Sud K., Vogel B., et al. Right ventricular dilation in hospitalized patients with COVID-19 infection. JACC Cardiovasc. Imaging. Nov 2020;13(11):2459&#x2013;2461. doi: 10.1016/j.jcmg.2020.05.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jcmg.2020.05.010</ArticleId><ArticleId IdType="pmc">PMC7228729</ArticleId><ArticleId IdType="pubmed">32426088</ArticleId></ArticleIdList></Reference><Reference><Citation>Mandal S., Barnett J., Brill S.E., et al. &#x2018;Long-COVID&#x2019;: a cross-sectional study of persisting symptoms, biomarker and imaging abnormalities following hospitalisation for COVID-19. Thorax. 2020 doi: 10.1136/thoraxjnl-2020-215818. Nov 10.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/thoraxjnl-2020-215818</ArticleId><ArticleId IdType="pmc">PMC7615158</ArticleId><ArticleId IdType="pubmed">33172844</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang C., Huang L., Wang Y., et al. 6-month consequences of COVID-19 in patients discharged from hospital: a cohort study. Lancet. 2021;397(10270):220&#x2013;232. doi: 10.1016/s0140-6736(20)32656-8. Jan 16.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s0140-6736(20)32656-8</ArticleId><ArticleId IdType="pmc">PMC7833295</ArticleId><ArticleId IdType="pubmed">33428867</ArticleId></ArticleIdList></Reference><Reference><Citation>Petersen M.S., Kristiansen M.F., Hanusson K.D., et al. Long COVID in the Faroe Islands - a longitudinal study among non-hospitalized patients. Clin. Infect. Dis. 2020 doi: 10.1093/cid/ciaa1792. Nov 30.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cid/ciaa1792</ArticleId><ArticleId IdType="pmc">PMC7799340</ArticleId><ArticleId IdType="pubmed">33252665</ArticleId></ArticleIdList></Reference><Reference><Citation>Logue J.K., Franko N.M., McCulloch D.J., et al. Sequelae in adults at 6 months after COVID-19 infection. JAMA Netw. Open. 2021;4(2):e210830. doi: 10.1001/jamanetworkopen.2021.0830.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamanetworkopen.2021.0830</ArticleId><ArticleId IdType="pmc">PMC7896197</ArticleId><ArticleId IdType="pubmed">33606031</ArticleId></ArticleIdList></Reference><Reference><Citation>Havervall S., Rosell A., Phillipson M., et al. Symptoms and functional impairment assessed 8 months after mild COVID-19 among health care workers. JAMA. 2021 doi: 10.1001/jama.2021.5612.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2021.5612</ArticleId><ArticleId IdType="pmc">PMC8027932</ArticleId><ArticleId IdType="pubmed">33825846</ArticleId></ArticleIdList></Reference><Reference><Citation>Knight D.S., Kotecha T., Razvi Y., et al. COVID-19: myocardial injury in survivors. Circulation. 2020;142(11):1120&#x2013;1122. doi: 10.1161/circulationaha.120.049252. Sep 15.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/circulationaha.120.049252</ArticleId><ArticleId IdType="pmc">PMC7492396</ArticleId><ArticleId IdType="pubmed">32673505</ArticleId></ArticleIdList></Reference><Reference><Citation>Rajpal S., Tong M.S., Borchers J., et al. Cardiovascular magnetic resonance findings in competitive athletes recovering from COVID-19 infection. JAMA Cardiol. 2021;1:116&#x2013;118.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7489396</ArticleId><ArticleId IdType="pubmed">32915194</ArticleId></ArticleIdList></Reference><Reference><Citation>Ferreira V.M., Schulz-Menger J., Holmvang G., et al. Cardiovascular magnetic resonance in nonischemic myocardial inflammation: expert recommendations. J. Am. Coll. Cardiol. 2018;72(24):3158&#x2013;3176. doi: 10.1016/j.jacc.2018.09.072. Dec 18.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jacc.2018.09.072</ArticleId><ArticleId IdType="pubmed">30545455</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang L., Zhao P., Tang D., et al. Cardiac involvement in patients recovered from COVID-2019 identified using magnetic resonance imaging. JACC Cardiovasc. Imaging. Nov 2020;13(11):2330&#x2013;2339. doi: 10.1016/j.jcmg.2020.05.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jcmg.2020.05.004</ArticleId><ArticleId IdType="pmc">PMC7214335</ArticleId><ArticleId IdType="pubmed">32763118</ArticleId></ArticleIdList></Reference><Reference><Citation>Puntmann V.O., Carerj M.L., Wieters I., et al. Outcomes of cardiovascular magnetic resonance imaging in patients recently recovered from coronavirus disease 2019 (COVID-19) JAMA Cardiol. 2020;5(11):1265&#x2013;1273. doi: 10.1001/jamacardio.2020.3557. Nov 1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamacardio.2020.3557</ArticleId><ArticleId IdType="pmc">PMC7385689</ArticleId><ArticleId IdType="pubmed">32730619</ArticleId></ArticleIdList></Reference><Reference><Citation>Kotecha T., Knight D.S., Razvi Y., et al. Patterns of myocardial injury in recovered troponin-positive COVID-19 patients assessed by cardiovascular magnetic resonance. Eur. Heart J. 2021 doi: 10.1093/eurheartj/ehab075.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/eurheartj/ehab075</ArticleId><ArticleId IdType="pmc">PMC7928984</ArticleId><ArticleId IdType="pubmed">33596594</ArticleId></ArticleIdList></Reference><Reference><Citation>Fu H., Zhang N., Zheng Y., et al. Risk stratification of cardiac sequelae detected using cardiac magnetic resonance in late convalescence at the six-month follow-up of recovered COVID-19 patients [published online ahead of print, 2021 Apr 19] J. Inf. Secur. 2021;S0163-4453(21):00202-4. doi: 10.1016/j.jinf.2021.04.016.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jinf.2021.04.016</ArticleId><ArticleId IdType="pmc">PMC8054525</ArticleId><ArticleId IdType="pubmed">33887285</ArticleId></ArticleIdList></Reference><Reference><Citation>Clark D.E., Parikh A., Dendy J.M., et al. COVID-19 Myocardial Pathology Evaluation in AthleTEs with Cardiac Magnetic Resonance (COMPETE CMR) Circulation. 2020 doi: 10.1161/circulationaha.120.052573. Dec 17.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/circulationaha.120.052573</ArticleId><ArticleId IdType="pmc">PMC7864610</ArticleId><ArticleId IdType="pubmed">33332151</ArticleId></ArticleIdList></Reference><Reference><Citation>Starekova J., Bluemke D.A., Bradham W.S., et al. Evaluation for myocarditis in competitive student athletes recovering from coronavirus disease 2019 with cardiac magnetic resonance imaging. JAMA Cardiol. 2021 doi: 10.1001/jamacardio.2020.7444. Jan 14.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamacardio.2020.7444</ArticleId><ArticleId IdType="pmc">PMC7809616</ArticleId><ArticleId IdType="pubmed">33443537</ArticleId></ArticleIdList></Reference><Reference><Citation>Moulson N., Petek B.J., Drezner J.A., et al. SARS-CoV-2 cardiac involvement in young competitive athletes [published online ahead of print, 2021 Apr 17] Circulation. 2021 doi: 10.1161/CIRCULATIONAHA.121.054824.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCULATIONAHA.121.054824</ArticleId><ArticleId IdType="pmc">PMC8300154</ArticleId><ArticleId IdType="pubmed">33866822</ArticleId></ArticleIdList></Reference><Reference><Citation>ProspJoy G., Artico J., Kurdi H., et al. Prospective case-control study of cardiovascular abnormalities 6 months following mild COVID-19 in healthcare workers [published online ahead of print, 2021 May 5] JACC Cardiovasc. Imaging. 2021 doi: 10.1016/j.jcmg.2021.04.011. S1936-878X(21)00356-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jcmg.2021.04.011</ArticleId><ArticleId IdType="pmc">PMC8105493</ArticleId><ArticleId IdType="pubmed">33975819</ArticleId></ArticleIdList></Reference><Reference><Citation>Aquaro G.D., Ghebru Habtemicael Y., Camastra G., et al. Prognostic value of repeating cardiac magnetic resonance in patients with acute myocarditis. J. Am. Coll. Cardiol. 2019;74(20):2439&#x2013;2448. doi: 10.1016/j.jacc.2019.08.1061. /11/19/2019.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jacc.2019.08.1061</ArticleId><ArticleId IdType="pubmed">31727281</ArticleId></ArticleIdList></Reference><Reference><Citation>Bryarly M., Phillips L.T., Fu Q., Vernino S., Levine B.D. Postural orthostatic tachycardia syndrome: JACC focus seminar. J. Am. Coll. Cardiol. 2019;73(10):1207&#x2013;1228. doi: 10.1016/j.jacc.2018.11.059. Mar 19.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jacc.2018.11.059</ArticleId><ArticleId IdType="pubmed">30871704</ArticleId></ArticleIdList></Reference><Reference><Citation>Goldstein D.S. The possible association between COVID-19 and postural tachycardia syndrome. Heart Rhythm. Apr 2021;18(4):508&#x2013;509. doi: 10.1016/j.hrthm.2020.12.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.hrthm.2020.12.007</ArticleId><ArticleId IdType="pmc">PMC7729277</ArticleId><ArticleId IdType="pubmed">33316414</ArticleId></ArticleIdList></Reference><Reference><Citation>Kanjwal K., Jamal S., Kichloo A., Grubb B.P. New-onset postural orthostatic tachycardia syndrome following coronavirus disease 2019 infection. J. Innov. Card. Rhythm Manag. 2020;11:4302&#x2013;4304. Copyright: &#xa9; 2020 Innovations in Cardiac Rhythm Management.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7685310</ArticleId><ArticleId IdType="pubmed">33262898</ArticleId></ArticleIdList></Reference><Reference><Citation>Miglis M.G., Prieto T., Shaik R., Muppidi S., Sinn D.I., Jaradeh S. A case report of postural tachycardia syndrome after COVID-19. Clin. Auton. Res. 2020;5:449&#x2013;451.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7471493</ArticleId><ArticleId IdType="pubmed">32880754</ArticleId></ArticleIdList></Reference><Reference><Citation>Umapathi T., Poh M.Q.W., Fan B.E., Li K.F.C., George J., Tan J.Y.L. Acute hyperhidrosis and postural tachycardia in a COVID-19 patient. Clin. Auton. Res. 2020;6:571&#x2013;573.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7511524</ArticleId><ArticleId IdType="pubmed">32970212</ArticleId></ArticleIdList></Reference><Reference><Citation>Johansson M, St&#xe5;hlberg M, Runold M, et al. Long-haul post&#x2013;COVID-19 symptoms presenting as a variant of postural orthostatic tachycardia syndrome. JACC Case Rep.. 0(0)doi:10.1016/j.jaccas.2021.01.009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jaccas.2021.01.009</ArticleId><ArticleId IdType="pmc">PMC7946344</ArticleId><ArticleId IdType="pubmed">33723532</ArticleId></ArticleIdList></Reference><Reference><Citation>Blitshteyn S., Whitelaw S. Postural orthostatic tachycardia syndrome (POTS) and other autonomic disorders after COVID-19 infection: a case series of 20 patients [published correction appears in Immunol Res. 2021 Apr 13;:] Immunol. Res. 2021;69(2):205&#x2013;211. doi: 10.1007/s12026-021-09185-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12026-021-09185-5</ArticleId><ArticleId IdType="pmc">PMC8009458</ArticleId><ArticleId IdType="pubmed">33786700</ArticleId></ArticleIdList></Reference><Reference><Citation>Goodman B.P., Khoury J.A., Blair J.E., Grill M.F. COVID-19 dysautonomia. Front. Neurol. 2021;12:624968. doi: 10.3389/fneur.2021.624968. Published 2021 Apr 13.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fneur.2021.624968</ArticleId><ArticleId IdType="pmc">PMC8076737</ArticleId><ArticleId IdType="pubmed">33927679</ArticleId></ArticleIdList></Reference><Reference><Citation>Shouman K., Vanichkachorn G., Cheshire W.P., et al. Autonomic dysfunction following COVID-19 infection: an early experience [published online ahead of print, 2021 Apr 16] Clin. Auton. Res. 2021:1&#x2013;10. doi: 10.1007/s10286-021-00803-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10286-021-00803-8</ArticleId><ArticleId IdType="pmc">PMC8050227</ArticleId><ArticleId IdType="pubmed">33860871</ArticleId></ArticleIdList></Reference><Reference><Citation>Fedorowski A. Postural orthostatic tachycardia syndrome: clinical presentation, aetiology and management. J. Intern. Med. 2019;285(4):352&#x2013;366. doi: 10.1111/joim.12852. 2019/04/01.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/joim.12852</ArticleId><ArticleId IdType="pubmed">30372565</ArticleId></ArticleIdList></Reference><Reference><Citation>Go&#xeb;rtz Y.M.J., Van Herck M., Delbressine J.M., et al. Persistent symptoms 3&#x202f;months after a SARS-CoV-2 infection: the post-COVID-19 syndrome? ERJ Open Res. Oct 2020;6(4) doi: 10.1183/23120541.00542-2020.</Citation><ArticleIdList><ArticleId IdType="doi">10.1183/23120541.00542-2020</ArticleId><ArticleId IdType="pmc">PMC7491255</ArticleId><ArticleId IdType="pubmed">33257910</ArticleId></ArticleIdList></Reference><Reference><Citation>Dherange P., Lang J., Qian P., et al. Arrhythmias and COVID-19: a review. JACC Clin. Electrophysiol. Sep 2020;6(9):1193&#x2013;1204. doi: 10.1016/j.jacep.2020.08.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jacep.2020.08.002</ArticleId><ArticleId IdType="pmc">PMC7417167</ArticleId><ArticleId IdType="pubmed">32972561</ArticleId></ArticleIdList></Reference><Reference><Citation>Angeli F., Spanevello A., De Ponti R., et al. Electrocardiographic features of patients with COVID-19 pneumonia. Eur. J. Intern. Med. Aug 2020;78:101&#x2013;106. doi: 10.1016/j.ejim.2020.06.015.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ejim.2020.06.015</ArticleId><ArticleId IdType="pmc">PMC7305928</ArticleId><ArticleId IdType="pubmed">32586646</ArticleId></ArticleIdList></Reference><Reference><Citation>Musikantow Daniel R, Turagam Mohit K, Sartori S, et al. Atrial fibrillation in patients hospitalized with COVID-19: incidence, predictors, outcomes and comparison to influenza. JACC Clin. Electrophysiol. 0(0)doi:10.1016/j.jacep.2021.02.009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jacep.2021.02.009</ArticleId><ArticleId IdType="pmc">PMC7904279</ArticleId><ArticleId IdType="pubmed">33895107</ArticleId></ArticleIdList></Reference><Reference><Citation>Al-Aly Z., Xie Y., Bowe B. High-dimensional characterization of post-acute sequelae of COVID-19 [published online ahead of print, 2021 Apr 22] Nature. 2021 doi: 10.1038/s41586-021-03553-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-021-03553-9</ArticleId><ArticleId IdType="pubmed">33887749</ArticleId></ArticleIdList></Reference><Reference><Citation>Seshadri D.R., Davies E.V., Harlow E.R., et al. Wearable sensors for COVID-19: a call to action to harness our digital infrastructure for remote patient monitoring and virtual assessments. Review. Front. Digit. Health. 2020;2(8) doi: 10.3389/fdgth.2020.00008. 2020-June-23.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fdgth.2020.00008</ArticleId><ArticleId IdType="pmc">PMC8521919</ArticleId><ArticleId IdType="pubmed">34713021</ArticleId></ArticleIdList></Reference><Reference><Citation>Khandaker M.H., Espinosa R.E., Nishimura R.A., et al. Pericardial disease: diagnosis and management. Mayo Clin. Proc. Jun 2010;85(6):572&#x2013;593. doi: 10.4065/mcp.2010.0046.</Citation><ArticleIdList><ArticleId IdType="doi">10.4065/mcp.2010.0046</ArticleId><ArticleId IdType="pmc">PMC2878263</ArticleId><ArticleId IdType="pubmed">20511488</ArticleId></ArticleIdList></Reference><Reference><Citation>Martinez M.W., Tucker A.M., Bloom O.J., et al. Prevalence of inflammatory heart disease among professional athletes with prior COVID-19 infection who received systematic return-to-play cardiac screening. JAMA Cardiol. 2021 doi: 10.1001/jamacardio.2021.0565.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamacardio.2021.0565</ArticleId><ArticleId IdType="pmc">PMC7934073</ArticleId><ArticleId IdType="pubmed">33662103</ArticleId></ArticleIdList></Reference><Reference><Citation>Chapman A.R., Shah A.S.V., Lee K.K., et al. Long-term outcomes in patients with type 2 myocardial infarction and myocardial injury. Circulation. 2018;137(12):1236&#x2013;1245. doi: 10.1161/circulationaha.117.031806. Mar 20.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/circulationaha.117.031806</ArticleId><ArticleId IdType="pmc">PMC5882250</ArticleId><ArticleId IdType="pubmed">29150426</ArticleId></ArticleIdList></Reference><Reference><Citation>DeFilippis A.P., Chapman A.R., Mills N.L., et al. Assessment and treatment of patients with type 2 myocardial infarction and acute nonischemic myocardial injury. Circulation. 2019;140(20):1661&#x2013;1678. doi: 10.1161/circulationaha.119.040631. Nov 12.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/circulationaha.119.040631</ArticleId><ArticleId IdType="pmc">PMC6855329</ArticleId><ArticleId IdType="pubmed">31416350</ArticleId></ArticleIdList></Reference><Reference><Citation>Al Abbasi B., Torres P., Ramos-Tuarez F., et al. Cardiac troponin-I and COVID-19: a prognostic tool for in-hospital mortality. Cardiol. Res. Dec 2020;11(6):398&#x2013;404. doi: 10.14740/cr1159.</Citation><ArticleIdList><ArticleId IdType="doi">10.14740/cr1159</ArticleId><ArticleId IdType="pmc">PMC7666590</ArticleId><ArticleId IdType="pubmed">33224386</ArticleId></ArticleIdList></Reference><Reference><Citation>Schiavone M., Gasperetti A., Mancone M., et al. Redefining the prognostic value of high-sensitivity troponin in COVID-19 patients: the importance of concomitant coronary artery disease. J. Clin. Med. 2020;9(10) doi: 10.3390/jcm9103263. Oct 12.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm9103263</ArticleId><ArticleId IdType="pmc">PMC7601151</ArticleId><ArticleId IdType="pubmed">33053826</ArticleId></ArticleIdList></Reference><Reference><Citation>Barman H.A., Atici A., Sahin I., et al. Prognostic significance of cardiac injury in COVID-19 patients with and without coronary artery disease. Coron. Artery Dis. 2020 doi: 10.1097/mca.0000000000000914. Jun 19.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/mca.0000000000000914</ArticleId><ArticleId IdType="pmc">PMC7365584</ArticleId><ArticleId IdType="pubmed">32568741</ArticleId></ArticleIdList></Reference><Reference><Citation>Nai Fovino L., Cademartiri F., Tarantini G. Subclinical coronary artery disease in COVID-19 patients. Eur. Heart J. Cardiovasc. Imaging. 2020;21(9):1055&#x2013;1056. doi: 10.1093/ehjci/jeaa202. Sep 1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ehjci/jeaa202</ArticleId><ArticleId IdType="pmc">PMC7454480</ArticleId><ArticleId IdType="pubmed">32671381</ArticleId></ArticleIdList></Reference><Reference><Citation>Ayoubkhani D., Khunti K., Nafilyan V., et al. Post-covid syndrome in individuals admitted to hospital with covid-19: retrospective cohort study. BMJ. 2021;372 doi: 10.1136/bmj.n693.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.n693</ArticleId><ArticleId IdType="pmc">PMC8010267</ArticleId><ArticleId IdType="pubmed">33789877</ArticleId></ArticleIdList></Reference><Reference><Citation>Madjid M., Safavi-Naeini P., Solomon S.D., Vardeny O. Potential effects of coronaviruses on the cardiovascular system: a review. JAMA Cardiol. 2020;5(7):831&#x2013;840. doi: 10.1001/jamacardio.2020.1286. Jul 1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamacardio.2020.1286</ArticleId><ArticleId IdType="pubmed">32219363</ArticleId></ArticleIdList></Reference><Reference><Citation>Moldofsky H., Patcai J. Chronic widespread musculoskeletal pain, fatigue, depression and disordered sleep in chronic post-SARS syndrome; a case-controlled study. BMC Neurol. 2011;11:37. doi: 10.1186/1471-2377-11-37. Mar 24.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1471-2377-11-37</ArticleId><ArticleId IdType="pmc">PMC3071317</ArticleId><ArticleId IdType="pubmed">21435231</ArticleId></ArticleIdList></Reference><Reference><Citation>Yancey J.R., Thomas S.M. Chronic fatigue syndrome: diagnosis and treatment. Am. Fam. Physician. 2012;86(8):741&#x2013;746. Oct 15.</Citation><ArticleIdList><ArticleId IdType="pubmed">23062157</ArticleId></ArticleIdList></Reference><Reference><Citation>Avellaneda Fern&#xe1;ndez A., P&#xe9;rez Mart&#xed;n A., Izquierdo Mart&#xed;nez M., et al. Chronic fatigue syndrome: aetiology, diagnosis and treatment. BMC Psychiatry. 2009;9(Suppl 1):S1. doi: 10.1186/1471-244x-9-s1-s1. Oct 23.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1471-244x-9-s1-s1</ArticleId><ArticleId IdType="pmc">PMC2766938</ArticleId><ArticleId IdType="pubmed">19857242</ArticleId></ArticleIdList></Reference><Reference><Citation>Castro-Marrero J., S&#xe1;ez-Franc&#xe0;s N., Santillo D., Alegre J. Treatment and management of chronic fatigue syndrome/myalgic encephalomyelitis: all roads lead to Rome. Br. J. Pharmacol. Mar 2017;174(5):345&#x2013;369. doi: 10.1111/bph.13702.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/bph.13702</ArticleId><ArticleId IdType="pmc">PMC5301046</ArticleId><ArticleId IdType="pubmed">28052319</ArticleId></ArticleIdList></Reference><Reference><Citation>Afrin L.B., Self S., Menk J., Lazarchick J. Characterization of mast cell activation syndrome. Am J Med Sci. Mar 2017;353(3):207&#x2013;215. doi: 10.1016/j.amjms.2016.12.013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.amjms.2016.12.013</ArticleId><ArticleId IdType="pmc">PMC5341697</ArticleId><ArticleId IdType="pubmed">28262205</ArticleId></ArticleIdList></Reference><Reference><Citation>Afrin L.B., Weinstock L.B., Molderings G.J. Covid-19 hyperinflammation and post-Covid-19 illness may be rooted in mast cell activation syndrome. Int. J. Infect. Dis. Nov 2020;100:327&#x2013;332. doi: 10.1016/j.ijid.2020.09.016.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijid.2020.09.016</ArticleId><ArticleId IdType="pmc">PMC7529115</ArticleId><ArticleId IdType="pubmed">32920235</ArticleId></ArticleIdList></Reference><Reference><Citation>Convertino V.A., Bloomfield S.A., Greenleaf J.E. An overview of the issues: physiological effects of bed rest and restricted physical activity. Med. Sci. Sports Exerc. 1997;29(2):187&#x2013;190. doi: 10.1097/00005768-199702000-00004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00005768-199702000-00004</ArticleId><ArticleId IdType="pubmed">9044221</ArticleId></ArticleIdList></Reference><Reference><Citation>Stremel R.W., Convertino V.A., Bernauer E.M., Greenleaf J.E. Cardiorespiratory deconditioning with static and dynamic leg exercise during bed rest. J. Appl. Physiol. 1976;41(6):905&#x2013;909. doi: 10.1152/jappl.1976.41.6.905.</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/jappl.1976.41.6.905</ArticleId><ArticleId IdType="pubmed">1002644</ArticleId></ArticleIdList></Reference><Reference><Citation>Joyner M.J., Masuki S. POTS versus deconditioning: the same or different? Clin. Auton. Res. 2008;18(6):300&#x2013;307. doi: 10.1007/s10286-008-0487-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10286-008-0487-7</ArticleId><ArticleId IdType="pmc">PMC3770293</ArticleId><ArticleId IdType="pubmed">18704621</ArticleId></ArticleIdList></Reference><Reference><Citation>Lechien J.R., Chiesa-Estomba C.M., Place S., et al. Clinical and epidemiological characteristics of 1420 European patients with mild-to-moderate coronavirus disease 2019. J. Intern. Med. 2020;288(3):335&#x2013;344. doi: 10.1111/joim.13089.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/joim.13089</ArticleId><ArticleId IdType="pmc">PMC7267446</ArticleId><ArticleId IdType="pubmed">32352202</ArticleId></ArticleIdList></Reference><Reference><Citation>McKinney J., Connelly K.A., Dorian P., et al. COVID-19-myocarditis and return to play: reflections and recommendations from a Canadian working group. Can. J. Cardiol. 2020 doi: 10.1016/j.cjca.2020.11.007. Nov 26.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cjca.2020.11.007</ArticleId><ArticleId IdType="pmc">PMC7688421</ArticleId><ArticleId IdType="pubmed">33248208</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim J.H., Levine B.D., Phelan D., et al. Coronavirus disease 2019 and the athletic heart: emerging perspectives on pathology, risks, and return to play. JAMA Cardiol. 2021;6(2):219&#x2013;227. doi: 10.1001/jamacardio.2020.5890. Feb 1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamacardio.2020.5890</ArticleId><ArticleId IdType="pubmed">33104154</ArticleId></ArticleIdList></Reference><Reference><Citation>Dores H., Cardim N. Return to play after COVID-19: a sport cardiologist's view. Br. J. Sports Med. 2020;19:1132&#x2013;1133.</Citation><ArticleIdList><ArticleId IdType="pubmed">32381502</ArticleId></ArticleIdList></Reference><Reference><Citation>Bhatia R.T., Marwaha S., Malhotra A., et al. Exercise in the severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) era: a question and answer session with the experts endorsed by the section of sports cardiology &amp; exercise of the European Association of Preventive Cardiology (EAPC) Eur. J. Prev. Cardiol. Aug 2020;27(12):1242&#x2013;1251. doi: 10.1177/2047487320930596.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/2047487320930596</ArticleId><ArticleId IdType="pmc">PMC7717284</ArticleId><ArticleId IdType="pubmed">32475157</ArticleId></ArticleIdList></Reference><Reference><Citation>Phelan D., Kim J.H., Chung E.H. A game plan for the resumption of sport and exercise after coronavirus disease 2019 (COVID-19) infection. JAMA Cardiol. 2020 doi: 10.1001/jamacardio.2020.2136. May 13.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamacardio.2020.2136</ArticleId><ArticleId IdType="pubmed">32402054</ArticleId></ArticleIdList></Reference><Reference><Citation>Castiello T., Georgiopoulos G., Finocchiaro G., et al. COVID-19 and myocarditis: a systematic review and overview of current challenges. Heart Fail. Rev. 2021:1&#x2013;11. doi: 10.1007/s10741-021-10087-9. Mar 24.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10741-021-10087-9</ArticleId><ArticleId IdType="pmc">PMC7988375</ArticleId><ArticleId IdType="pubmed">33761041</ArticleId></ArticleIdList></Reference><Reference><Citation>Pelliccia A., Solberg E.E., Papadakis M., et al. Recommendations for participation in competitive and leisure time sport in athletes with cardiomyopathies, myocarditis, and pericarditis: position statement of the Sport Cardiology Section of the European Association of Preventive Cardiology (EAPC) Eur. Heart J. 2019;40(1):19&#x2013;33. doi: 10.1093/eurheartj/ehy730.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/eurheartj/ehy730</ArticleId><ArticleId IdType="pubmed">30561613</ArticleId></ArticleIdList></Reference><Reference><Citation>Brigham E., O'Toole J., Kim S.Y., et al. The Johns Hopkins Post-Acute COVID-19 Team (PACT): a multidisciplinary, collaborative, ambulatory framework supporting COVID-19 survivors. Am. J. Med. 2021 doi: 10.1016/j.amjmed.2020.12.009. Jan 12.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.amjmed.2020.12.009</ArticleId><ArticleId IdType="pmc">PMC7801819</ArticleId><ArticleId IdType="pubmed">33444589</ArticleId></ArticleIdList></Reference><Reference><Citation>O'Brien H., Tracey M.J., Ottewill C., et al. An integrated multidisciplinary model of COVID-19 recovery care. Ir. J. Med. Sci. 2020:1&#x2013;8. doi: 10.1007/s11845-020-02354-9. Sep 7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11845-020-02354-9</ArticleId><ArticleId IdType="pmc">PMC7475726</ArticleId><ArticleId IdType="pubmed">32894436</ArticleId></ArticleIdList></Reference><Reference><Citation>Biehl M., Sese D. Post-intensive care syndrome and COVID-19 - implications post pandemic. Cleve. Clin. J. Med. 2020 doi: 10.3949/ccjm.87a.ccc055. Aug 5.</Citation><ArticleIdList><ArticleId IdType="doi">10.3949/ccjm.87a.ccc055</ArticleId><ArticleId IdType="pubmed">32759175</ArticleId></ArticleIdList></Reference><Reference><Citation>UCLA COVID Cardiology Clinic UCLA COVID Cardiology Clinic - UCLA Heart and Vascular Services - Los Angeles, CA. https://www.uclahealth.org/heart/covid-cardiology</Citation></Reference><Reference><Citation>Polack F.P., Thomas S.J., Kitchin N., et al. Safety and efficacy of the BNT162b2 mRNA Covid-19 vaccine. N. Engl. J. Med. 2020;383(27):2603&#x2013;2615. doi: 10.1056/NEJMoa2034577. Dec 31.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa2034577</ArticleId><ArticleId IdType="pmc">PMC7745181</ArticleId><ArticleId IdType="pubmed">33301246</ArticleId></ArticleIdList></Reference><Reference><Citation>Baden L.R., El Sahly H.M., Essink B., et al. Efficacy and safety of the mRNA-1273 SARS-CoV-2 vaccine. N. Engl. J. Med. 2021;384(5):403&#x2013;416. doi: 10.1056/NEJMoa2035389. Feb 4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa2035389</ArticleId><ArticleId IdType="pmc">PMC7787219</ArticleId><ArticleId IdType="pubmed">33378609</ArticleId></ArticleIdList></Reference><Reference><Citation>Collins F.S. 2021. NIH Launches New Initiative to Study &#x201c;Long COVID&#x201d;. Accessed 04/10/</Citation></Reference><Reference><Citation>Chopra V., Flanders S.A., O'Malley M., Malani A.N., Prescott H.C. Sixty-day outcomes among patients hospitalized with COVID-19. Ann. Intern. Med. 2020</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7707210</ArticleId><ArticleId IdType="pubmed">33175566</ArticleId></ArticleIdList></Reference><Reference><Citation>Carf&#xec; A., Bernabei R., Landi F. Persistent symptoms in patients after acute COVID-19. Jama. 2020;324(6):603&#x2013;605. doi: 10.1001/jama.2020.12603. Aug 11.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2020.12603</ArticleId><ArticleId IdType="pmc">PMC7349096</ArticleId><ArticleId IdType="pubmed">32644129</ArticleId></ArticleIdList></Reference><Reference><Citation>Xiong Q., Xu M., Li J., et al. Clinical sequelae of COVID-19 survivors in Wuhan, China: a single-centre longitudinal study. Clin. Microbiol. Infect. Jan 2021;27(1):89&#x2013;95. doi: 10.1016/j.cmi.2020.09.023.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cmi.2020.09.023</ArticleId><ArticleId IdType="pmc">PMC7510771</ArticleId><ArticleId IdType="pubmed">32979574</ArticleId></ArticleIdList></Reference><Reference><Citation>Kamal M., Abo Omirah M., Hussein A., Saeed H. Assessment and characterisation of post-COVID-19 manifestations. Int. J. Clin. Pract. 2020:e13746. doi: 10.1111/ijcp.13746. Sep 29.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/ijcp.13746</ArticleId><ArticleId IdType="pmc">PMC7536922</ArticleId><ArticleId IdType="pubmed">32991035</ArticleId></ArticleIdList></Reference><Reference><Citation>Carvalho-Schneider C., Laurent E., Lemaignen A., et al. Follow-up of adults with noncritical COVID-19 two months after symptom onset. Clin. Microbiol. Infect. 2020 doi: 10.1016/j.cmi.2020.09.052. Oct 5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cmi.2020.09.052</ArticleId><ArticleId IdType="pmc">PMC7534895</ArticleId><ArticleId IdType="pubmed">33031948</ArticleId></ArticleIdList></Reference><Reference><Citation>Garrigues E., Janvier P., Kherabi Y., et al. Post-discharge persistent symptoms and health-related quality of life after hospitalization for COVID-19. J. Inf. Secur. Dec 2020;81(6):e4&#x2013;e6. doi: 10.1016/j.jinf.2020.08.029.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jinf.2020.08.029</ArticleId><ArticleId IdType="pmc">PMC7445491</ArticleId><ArticleId IdType="pubmed">32853602</ArticleId></ArticleIdList></Reference><Reference><Citation>Halpin S.J., McIvor C., Whyatt G., et al. Postdischarge symptoms and rehabilitation needs in survivors of COVID-19 infection: a cross-sectional evaluation. J. Med. Virol. Feb 2021;93(2):1013&#x2013;1022. doi: 10.1002/jmv.26368.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.26368</ArticleId><ArticleId IdType="pubmed">32729939</ArticleId></ArticleIdList></Reference><Reference><Citation>Moreno-P&#xe9;rez O., Merino E., Leon-Ramirez J.M., et al. Post-acute COVID-19 syndrome. Incidence and risk factors: a Mediterranean cohort study. J. Inf. Secur. 2021 doi: 10.1016/j.jinf.2021.01.004. Jan 12.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jinf.2021.01.004</ArticleId><ArticleId IdType="pmc">PMC7802523</ArticleId><ArticleId IdType="pubmed">33450302</ArticleId></ArticleIdList></Reference><Reference><Citation>The Writing Committee for the CSG Four-month clinical status of a cohort of patients after hospitalization for COVID-19. JAMA. 2021 doi: 10.1001/jama.2021.3331.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2021.3331</ArticleId><ArticleId IdType="pmc">PMC7970386</ArticleId><ArticleId IdType="pubmed">33729425</ArticleId></ArticleIdList></Reference><Reference><Citation>Shang Y.F., Liu T., Yu J.N., et al. Half-year follow-up of patients recovering from severe COVID-19: Analysis of symptoms and their risk factors [published online ahead of print, 2021 Apr 27] J. Intern. Med. 2021 doi: 10.1111/joim.13284.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/joim.13284</ArticleId><ArticleId IdType="pmc">PMC8242565</ArticleId><ArticleId IdType="pubmed">33904618</ArticleId></ArticleIdList></Reference><Reference><Citation>Meije Y., Duarte-Borges A., Sanz X., et al. Long-term outcomes of patients following hospitalization for coronavirus disease 2019: a prospective observational study [published online ahead of print, 2021 Apr 23] Clin. Microbiol. Infect. 2021 doi: 10.1016/j.cmi.2021.04.002. S1198-743X(21)00170-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cmi.2021.04.002</ArticleId><ArticleId IdType="pmc">PMC8062910</ArticleId><ArticleId IdType="pubmed">33901667</ArticleId></ArticleIdList></Reference><Reference><Citation>Armange L., B&#xe9;n&#xe9;zit F., Picard L., et al. Prevalence and characteristics of persistent symptoms after non-severe COVID-19: a prospective cohort study [published online ahead of print, 2021 Apr 23] Eur. J. Clin. Microbiol. Infect. Dis. 2021:1&#x2013;5. doi: 10.1007/s10096-021-04261-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10096-021-04261-y</ArticleId><ArticleId IdType="pmc">PMC8064701</ArticleId><ArticleId IdType="pubmed">33893570</ArticleId></ArticleIdList></Reference><Reference><Citation>Darley D.R., Dore G.J., Cysique L., et al. Persistent symptoms up to four months after community and hospital-managed SARS-CoV-2 infection. Med. J. Aust. 2021;214(6):279&#x2013;280. doi: 10.5694/mja2.50963.</Citation><ArticleIdList><ArticleId IdType="doi">10.5694/mja2.50963</ArticleId><ArticleId IdType="pmc">PMC8014234</ArticleId><ArticleId IdType="pubmed">33657671</ArticleId></ArticleIdList></Reference><Reference><Citation>Jacobson K.B., Rao M., Bonilla H., et al. Patients with uncomplicated COVID-19 have long-term persistent symptoms and functional impairment similar to patients with severe COVID-19: a cautionary tale during a global pandemic [published online ahead of print, 2021 Feb 7] Clin. Infect. Dis. 2021:ciab103. doi: 10.1093/cid/ciab103.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cid/ciab103</ArticleId><ArticleId IdType="pmc">PMC7929039</ArticleId><ArticleId IdType="pubmed">33624010</ArticleId></ArticleIdList></Reference><Reference><Citation>de Graaf M.A., Antoni M.L., Ter Kuile M.M., et al. Short-term outpatient follow-up of COVID-19 patients: a multidisciplinary approach. EClinicalMedicine. 2021;32:100731. doi: 10.1016/j.eclinm.2021.100731.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.eclinm.2021.100731</ArticleId><ArticleId IdType="pmc">PMC7843037</ArticleId><ArticleId IdType="pubmed">33532720</ArticleId></ArticleIdList></Reference><Reference><Citation>Venturelli S., Benatti S.V., Casati M., et al. Surviving COVID-19 in Bergamo province: a post-acute outpatient re-evaluation. Epidemiol. Infect. 2021;149:e32. doi: 10.1017/S0950268821000145. Published 2021 Jan 19.</Citation><ArticleIdList><ArticleId IdType="doi">10.1017/S0950268821000145</ArticleId><ArticleId IdType="pmc">PMC7873454</ArticleId><ArticleId IdType="pubmed">33461632</ArticleId></ArticleIdList></Reference><Reference><Citation>Liang L., Yang B., Jiang N., et al. Three-month follow-up study of survivors of coronavirus disease 2019 after discharge. J. Korean Med. Sci. 2020;35(47):e418. doi: 10.3346/jkms.2020.35.e418. Published 2020 Dec 7.</Citation><ArticleIdList><ArticleId IdType="doi">10.3346/jkms.2020.35.e418</ArticleId><ArticleId IdType="pmc">PMC7721559</ArticleId><ArticleId IdType="pubmed">33289374</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>